{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:12:14Z","timestamp":1778735534285,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000106","name":"Saskatchewan Health Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000106","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008920","name":"University of Saskatchewan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-137154"],"award-info":[{"award-number":["MOP-137154"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017294","name":"Saskatchewan Cancer Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02270-3","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T17:36:39Z","timestamp":1775237799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CLIC3 is upregulated across all subtypes of breast cancer and plays a key role in cell migration, invasion and growth in soft agar"],"prefix":"10.1186","volume":"28","author":[{"given":"Paul","family":"Mellor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shari E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Kendall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliia","family":"Kyrylenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alissar","family":"Monzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Goubran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah H.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"key":"2270_CR1","unstructured":"Breast Cancer Statistics. https:\/\/cancer.ca\/en\/cancer-information\/cancer-types\/breast\/statistics?_ga=2.263777804.1429687422.1641410797-1677001365.1619734808"},{"key":"2270_CR2","unstructured":"Breast Cancer. https:\/\/www.cancer.org\/cancer\/breast-cancer\/understanding-a-breast-cancer-diagnosis\/breast-cancer-survival-rates.html"},{"key":"2270_CR3","unstructured":"Types of Breast Cancer. http:\/\/www.bcsc.ca\/p\/41\/l\/506\/t\/Breast-Cancer-Society-of-Canada---Types-of-Breast-Cancer"},{"issue":"6","key":"2270_CR4","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.ctrv.2011.11.005","volume":"38","author":"P Eroles","year":"2012","unstructured":"Eroles P, Bosch A, Perez-Fidalgo JA, Lluch A. Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. Cancer Treat Rev. 2012;38(6):698\u2013707.","journal-title":"Cancer Treat Rev"},{"issue":"24","key":"2270_CR5","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1128\/MCB.00959-13","volume":"33","author":"P Mellor","year":"2013","unstructured":"Mellor P, Deibert L, Calvert B, Bonham K, Carlsen SA, Anderson DH. CREB3L1 is a metastasis suppressor that represses expression of genes regulating metastasis, invasion and angiogenesis. Mol Cell Biol. 2013;33(24):4985\u201395.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"2270_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13058-016-0672-x","volume":"18","author":"AK Ward","year":"2016","unstructured":"Ward AK, Mellor P, Smith SE, Kendall S, Just NA, Vizeacoumar FS, Sarker S, Phillips Z, Alvi R, Saxena A, et al. Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers. Breast Cancer Res. 2016;18(1):12.","journal-title":"Breast Cancer Res"},{"issue":"12","key":"2270_CR7","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.4161\/15592294.2014.988052","volume":"9","author":"M Rose","year":"2014","unstructured":"Rose M, Schubert C, Dierichs L, Gaisa NT, Heer M, Heidenreich A, Knuchel R, Dahl E. OASIS\/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro. Epigenetics: official J DNA Methylation Soc. 2014;9(12):1626\u201340.","journal-title":"Epigenetics: official J DNA Methylation Soc"},{"issue":"7","key":"2270_CR8","doi-asserted-by":"publisher","first-page":"e0271090","DOI":"10.1371\/journal.pone.0271090","volume":"17","author":"P Mellor","year":"2022","unstructured":"Mellor P, Kendall S, Smith S, Saxena A, Anderson DH. Reduced CREB3L1 expression in triple negative and luminal a breast cancer cells contributes to enhanced cell migration, anchorage-independent growth and metastasis. PLoS ONE. 2022;17(7):e0271090.","journal-title":"PLoS ONE"},{"key":"2270_CR9","doi-asserted-by":"publisher","first-page":"4817924","DOI":"10.1155\/2024\/4817924","volume":"2024","author":"S Cong","year":"2024","unstructured":"Cong S, Fu Y, Zhao X, Guo Q, Liang T, Wu D, Wang J, Zhang G. KIF26B and CREB3L1 Derived from Immunoscore Could Inhibit the Progression of Ovarian Cancer. J Immunol Res. 2024;2024:4817924.","journal-title":"J Immunol Res"},{"key":"2270_CR10","doi-asserted-by":"crossref","unstructured":"Mellor P, Kendall S, Hammond SA, Plett R, Kyrylenko L, Saxena A, Anderson DH. Expression of CREB3L1 blocks key cancer pathways and suppresses metastasis of lung squamous cell carcinoma cells. Biochim Biophys Acta Mol Basis Dis. 2025:167845.","DOI":"10.1016\/j.bbadis.2025.167845"},{"issue":"1","key":"2270_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0006-291X(02)00253-X","volume":"293","author":"Y Omori","year":"2002","unstructured":"Omori Y, Imai J, Suzuki Y, Watanabe S, Tanigami A, Sugano S. OASIS is a transcriptional activator of CREB\/ATF family with a transmembrane domain. Biochem Biophys Res Commun. 2002;293(1):470\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"2270_CR12","doi-asserted-by":"publisher","first-page":"8144","DOI":"10.1074\/jbc.M111.332593","volume":"287","author":"R Asada","year":"2012","unstructured":"Asada R, Saito A, Kawasaki N, Kanemoto S, Iwamoto H, Oki M, Miyagi H, Izumi S, Imaizumi K. The endoplasmic reticulum stress transducer OASIS is involved in the terminal differentiation of goblet cells in the large intestine. J Biol Chem. 2012;287(11):8144\u201353.","journal-title":"J Biol Chem"},{"issue":"4","key":"2270_CR13","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/j.1471-4159.2005.03596.x","volume":"96","author":"T Murakami","year":"2006","unstructured":"Murakami T, Kondo S, Ogata M, Kanemoto S, Saito A, Wanaka A, Imaizumi K. Cleavage of the membrane-bound transcription factor OASIS in response to endoplasmic reticulum stress. J Neurochem. 2006;96(4):1090\u2013100.","journal-title":"J Neurochem"},{"issue":"7","key":"2270_CR14","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1158\/0008-5472.CAN-07-6055","volume":"68","author":"X Ouyang","year":"2008","unstructured":"Ouyang X, Jessen WJ, Al-Ahmadie H, Serio AM, Lin Y, Shih WJ, Reuter VE, Scardino PT, Shen MM, Aronow BJ, et al. Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer. Cancer Res. 2008;68(7):2132\u201344.","journal-title":"Cancer Res"},{"issue":"4","key":"2270_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00109-006-0150-5","volume":"85","author":"P Scriven","year":"2007","unstructured":"Scriven P, Brown NJ, Pockley AG, Wyld L. The unfolded protein response and cancer: a brighter future unfolding? J Mol Med. 2007;85(4):331\u201341.","journal-title":"J Mol Med"},{"issue":"1\u20132","key":"2270_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10555-008-9180-5","volume":"28","author":"AY So","year":"2009","unstructured":"So AY, de la Fuente E, Walter P, Shuman M, Bernales S. The unfolded protein response during prostate cancer development. Cancer Metastasis Rev. 2009;28(1\u20132):219\u201323.","journal-title":"Cancer Metastasis Rev"},{"issue":"47","key":"2270_CR17","doi-asserted-by":"publisher","first-page":"48607","DOI":"10.1074\/jbc.M409769200","volume":"279","author":"MD Chamberlain","year":"2004","unstructured":"Chamberlain MD, Berry TR, Pastor MC, Anderson DH. The p85alpha Subunit of Phosphatidylinositol 3\u2019-Kinase Binds to and Stimulates the GTPase Activity of Rab Proteins. J Biol Chem. 2004;279(47):48607\u201314.","journal-title":"J Biol Chem"},{"key":"2270_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12859-015-0611-3","volume":"16","author":"H Heberle","year":"2015","unstructured":"Heberle H, Meirelles GV, da Silva FR, Telles GP, Minghim R. InteractiVenn: a web-based tool for the analysis of sets through Venn diagrams. BMC Bioinformatics. 2015;16:169.","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"2270_CR19","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gyorffy","year":"2010","unstructured":"Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, Szallasi Z. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010;123(3):725\u201331.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"2270_CR20","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.1038\/s41598-021-84787-5","volume":"11","author":"A Nagy","year":"2021","unstructured":"Nagy A, Munkacsy G, Gyorffy B. Pancancer survival analysis of cancer hallmark genes. Sci Rep. 2021;11(1):6047.","journal-title":"Sci Rep"},{"issue":"Suppl 5","key":"2270_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12920-019-0514-7","volume":"12","author":"SJ Park","year":"2019","unstructured":"Park SJ, Yoon BH, Kim SK, Kim SY. GENT2: an updated gene expression database for normal and tumor tissues. BMC Med Genom. 2019;12(Suppl 5):101.","journal-title":"BMC Med Genom"},{"issue":"3","key":"2270_CR22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/cam4.616","volume":"5","author":"Y Su","year":"2016","unstructured":"Su Y, Pogash TJ, Nguyen TD, Russo J. Development and characterization of two human triple-negative breast cancer cell lines with highly tumorigenic and metastatic capabilities. Cancer Med. 2016;5(3):558\u201373.","journal-title":"Cancer Med"},{"issue":"1\u20132","key":"2270_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0169-328X(02)00521-1","volume":"108","author":"T Nikaido","year":"2002","unstructured":"Nikaido T, Iseki K, Mori T, Takaki H, Yokoya S, Hagino S, Takeda J, Zhang Y, Takeuchi M, Kikuchi S, et al. Expression of OASIS, a CREB\/ATF family transcription factor, in CNS lesion and its transcriptional activity. Brain Res Mol brain Res. 2002;108(1\u20132):129\u201338.","journal-title":"Brain Res Mol brain Res"},{"key":"2270_CR24","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3389\/fonc.2020.01500","volume":"10","author":"A Raiter","year":"2020","unstructured":"Raiter A, Lipovetsky J, Hyman L, Mugami S, Ben-Zur T, Yerushalmi R. Chemotherapy Controls Metastasis Through Stimulatory Effects on GRP78 and Its Transcription Factor CREB3L1. Front Oncol. 2020;10:1500.","journal-title":"Front Oncol"},{"key":"2270_CR25","doi-asserted-by":"crossref","unstructured":"Mellor P, Kendall S, Hammond SA, Plett R, Saxena A, Anderson DH. Expression of CREB3L1 blocks key cancer pathways and suppresses metastasis of lung squamous cell carcinoma cells. Lung Cancer. 2025., TDB.","DOI":"10.1016\/j.bbadis.2025.167845"},{"issue":"8","key":"2270_CR26","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1016\/j.bbadis.2018.04.011","volume":"1864","author":"KC Park","year":"2018","unstructured":"Park KC, Menezes SV, Kalinowski DS, Sahni S, Jansson PJ, Kovacevic Z, Richardson DR. Identification of differential phosphorylation and sub-cellular localization of the metastasis suppressor, NDRG1. Biochim Biophys Acta Mol Basis Dis. 2018;1864(8):2644\u201363.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"33","key":"2270_CR27","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1038\/sj.onc.1207734","volume":"23","author":"S Bandyopadhyay","year":"2004","unstructured":"Bandyopadhyay S, Pai SK, Hirota S, Hosobe S, Takano Y, Saito K, Piquemal D, Commes T, Watabe M, Gross SC, et al. Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene. 2004;23(33):5675\u201381.","journal-title":"Oncogene"},{"issue":"9","key":"2270_CR28","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/pros.22978","volume":"75","author":"G Ding","year":"2015","unstructured":"Ding G, Fang J, Tong S, Qu L, Jiang H, Ding Q, Liu J. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer. Prostate. 2015;75(9):957\u201368.","journal-title":"Prostate"},{"issue":"5","key":"2270_CR29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/labinvest.2009.17","volume":"89","author":"L Hu","year":"2009","unstructured":"Hu L, Hittelman W, Lu T, Ji P, Arlinghaus R, Shmulevich I, Hamilton SR, Zhang W. NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells. Lab Invest. 2009;89(5):531\u201348.","journal-title":"Lab Invest"},{"issue":"10","key":"2270_CR30","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1073\/pnas.0810617106","volume":"106","author":"J Yang","year":"2009","unstructured":"Yang J, Bielenberg DR, Rodig SJ, Doiron R, Clifton MC, Kung AL, Strong RK, Zurakowski D, Moses MA. Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci USA. 2009;106(10):3913\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2270_CR31","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10549-007-9619-3","volume":"108","author":"M Bauer","year":"2008","unstructured":"Bauer M, Eickhoff JC, Gould MN, Mundhenke C, Maass N, Friedl A. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res Treat. 2008;108(3):389\u201397.","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"2270_CR32","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/j.ejca.2007.05.013","volume":"43","author":"FJ Kubben","year":"2007","unstructured":"Kubben FJ, Sier CF, Hawinkels LJ, Tschesche H, van Duijn W, Zuidwijk K, van der Reijden JJ, Hanemaaijer R, Griffioen G, Lamers CB, et al. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. Eur J Cancer. 2007;43(12):1869\u201376.","journal-title":"Eur J Cancer"},{"issue":"40","key":"2270_CR33","doi-asserted-by":"publisher","first-page":"37258","DOI":"10.1074\/jbc.M106089200","volume":"276","author":"L Yan","year":"2001","unstructured":"Yan L, Borregaard N, Kjeldsen L, Moses MA. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B\/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem. 2001;276(40):37258\u201365.","journal-title":"J Biol Chem"},{"issue":"22","key":"2270_CR34","doi-asserted-by":"publisher","first-page":"8579","DOI":"10.1158\/0008-5472.CAN-09-1934","volume":"69","author":"X Leng","year":"2009","unstructured":"Leng X, Ding T, Lin H, Wang Y, Hu L, Hu J, Feig B, Zhang W, Pusztai L, Symmans WF, et al. Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Res. 2009;69(22):8579\u201384.","journal-title":"Cancer Res"},{"issue":"5\u20136","key":"2270_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.placenta.2006.08.002","volume":"28","author":"TT Money","year":"2007","unstructured":"Money TT, King RG, Wong MH, Stevenson JL, Kalionis B, Erwich JJ, Huisman MA, Timmer A, Hiden U, Desoye G, et al. Expression and cellular localisation of chloride intracellular channel 3 in human placenta and fetal membranes. Placenta. 2007;28(5\u20136):429\u201336.","journal-title":"Placenta"},{"issue":"3","key":"2270_CR36","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1074\/jbc.274.3.1621","volume":"274","author":"Z Qian","year":"1999","unstructured":"Qian Z, Okuhara D, Abe MK, Rosner MR. Molecular cloning and characterization of a mitogen-activated protein kinase-associated intracellular chloride channel. J Biol Chem. 1999;274(3):1621\u20137.","journal-title":"J Biol Chem"},{"issue":"22","key":"2270_CR37","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1242\/jcs.189795","volume":"129","author":"E Argenzio","year":"2016","unstructured":"Argenzio E, Moolenaar WH. Emerging biological roles of Cl- intracellular channel proteins. J Cell Sci. 2016;129(22):4165\u201374.","journal-title":"J Cell Sci"},{"issue":"10","key":"2270_CR38","doi-asserted-by":"publisher","first-page":"9298","DOI":"10.1074\/jbc.M308444200","volume":"279","author":"DR Littler","year":"2004","unstructured":"Littler DR, Harrop SJ, Fairlie WD, Brown LJ, Pankhurst GJ, Pankhurst S, DeMaere MZ, Campbell TJ, Bauskin AR, Tonini R, et al. The intracellular chloride ion channel protein CLIC1 undergoes a redox-controlled structural transition. J Biol Chem. 2004;279(10):9298\u2013305.","journal-title":"J Biol Chem"},{"issue":"6","key":"2270_CR39","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/prot.22675","volume":"78","author":"DR Littler","year":"2010","unstructured":"Littler DR, Brown LJ, Breit SN, Perrakis A, Curmi PM. Structure of human CLIC3 at 2 A resolution. Proteins. 2010;78(6):1594\u2013600.","journal-title":"Proteins"},{"key":"2270_CR40","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fphys.2020.00096","volume":"11","author":"S Gururaja Rao","year":"2020","unstructured":"Gururaja Rao S, Patel NJ, Singh H. Intracellular Chloride Channels: Novel Biomarkers in Diseases. Front Physiol. 2020;11:96.","journal-title":"Front Physiol"},{"issue":"1","key":"2270_CR41","doi-asserted-by":"publisher","first-page":"e115699","DOI":"10.1371\/journal.pone.0115699","volume":"10","author":"H Al Khamici","year":"2015","unstructured":"Al Khamici H, Brown LJ, Hossain KR, Hudson AL, Sinclair-Burton AA, Ng JP, Daniel EL, Hare JE, Cornell BA, Curmi PM, et al. Members of the chloride intracellular ion channel protein family demonstrate glutaredoxin-like enzymatic activity. PLoS ONE. 2015;10(1):e115699.","journal-title":"PLoS ONE"},{"issue":"5","key":"2270_CR42","doi-asserted-by":"publisher","first-page":"C1103","DOI":"10.1152\/ajpcell.00402.2001","volume":"282","author":"BM Tulk","year":"2002","unstructured":"Tulk BM, Kapadia S, Edwards JC. CLIC1 inserts from the aqueous phase into phospholipid membranes, where it functions as an anion channel. Am J Physiol Cell Physiol. 2002;282(5):C1103\u20131112.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"29","key":"2270_CR43","doi-asserted-by":"publisher","first-page":"26003","DOI":"10.1074\/jbc.M203666200","volume":"277","author":"K Warton","year":"2002","unstructured":"Warton K, Tonini R, Fairlie WD, Matthews JM, Valenzuela SM, Qiu MR, Wu WM, Pankhurst S, Bauskin AR, Harrop SJ, et al. Recombinant CLIC1 (NCC27) assembles in lipid bilayers via a pH-dependent two-state process to form chloride ion channels with identical characteristics to those observed in Chinese hamster ovary cells expressing CLIC1. J Biol Chem. 2002;277(29):26003\u201311.","journal-title":"J Biol Chem"},{"issue":"Pt 22","key":"2270_CR44","first-page":"5479","volume":"125","author":"L Jiang","year":"2012","unstructured":"Jiang L, Salao K, Li H, Rybicka JM, Yates RM, Luo XW, Shi XX, Kuffner T, Tsai VW, Husaini Y, et al. Intracellular chloride channel protein CLIC1 regulates macrophage function through modulation of phagosomal acidification. J Cell Sci. 2012;125(Pt 22):5479\u201388.","journal-title":"J Cell Sci"},{"issue":"Pt 18","key":"2270_CR45","first-page":"3893","volume":"127","author":"IR Macpherson","year":"2014","unstructured":"Macpherson IR, Rainero E, Mitchell LE, van den Berghe PV, Speirs C, Dozynkiewicz MA, Chaudhary S, Kalna G, Edwards J, Timpson P, et al. CLIC3 controls recycling of late endosomal MT1-MMP and dictates invasion and metastasis in breast cancer. J Cell Sci. 2014;127(Pt 18):3893\u2013901.","journal-title":"J Cell Sci"},{"issue":"1","key":"2270_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.devcel.2011.11.008","volume":"22","author":"MA Dozynkiewicz","year":"2012","unstructured":"Dozynkiewicz MA, Jamieson NB, Macpherson I, Grindlay J, van den Berghe PV, von Thun A, Morton JP, Gourley C, Timpson P, Nixon C, et al. Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes\/lysosomes and drive cancer progression. Dev Cell. 2012;22(1):131\u201345.","journal-title":"Dev Cell"},{"issue":"13","key":"2270_CR47","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1158\/0008-5472.CAN-10-4376","volume":"71","author":"JY Perentes","year":"2011","unstructured":"Perentes JY, Kirkpatrick ND, Nagano S, Smith EY, Shaver CM, Sgroi D, Garkavtsev I, Munn LL, Jain RK, Boucher Y. Cancer cell-associated MT1-MMP promotes blood vessel invasion and distant metastasis in triple-negative mammary tumors. Cancer Res. 2011;71(13):4527\u201338.","journal-title":"Cancer Res"},{"issue":"2","key":"2270_CR48","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1158\/1541-7786.MCR-12-0300","volume":"11","author":"LM Knowles","year":"2013","unstructured":"Knowles LM, Zewe J, Malik G, Parwani AV, Gingrich JR, Pilch J. CLT1 targets bladder cancer through integrin alpha5beta1 and CLIC3. Mol cancer research: MCR. 2013;11(2):194\u2013203.","journal-title":"Mol cancer research: MCR"},{"issue":"12","key":"2270_CR49","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.oraloncology.2015.09.010","volume":"51","author":"Z Wang","year":"2015","unstructured":"Wang Z, Ling S, Rettig E, Sobel R, Tan M, Fertig EJ, Considine M, El-Naggar AK, Brait M, Fakhry C, et al. Epigenetic screening of salivary gland mucoepidermoid carcinoma identifies hypomethylation of CLIC3 as a common alteration. Oral Oncol. 2015;51(12):1120\u20135.","journal-title":"Oral Oncol"},{"issue":"24","key":"2270_CR50","doi-asserted-by":"publisher","first-page":"20661","DOI":"10.18632\/oncotarget.3861","volume":"6","author":"X Gu","year":"2015","unstructured":"Gu X, Li B, Jiang M, Fang M, Ji J, Wang A, Wang M, Jiang X, Gao C. RNA sequencing reveals differentially expressed genes as potential diagnostic and prognostic indicators of gallbladder carcinoma. Oncotarget. 2015;6(24):20661\u201371.","journal-title":"Oncotarget"},{"key":"2270_CR51","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2147\/OTT.S183944","volume":"12","author":"X Liu","year":"2019","unstructured":"Liu X, Wang J, Chen M, Liu S, Yu X, Wen F. Combining data from TCGA and GEO databases and reverse transcription quantitative PCR validation to identify gene prognostic markers in lung cancer. OncoTargets therapy. 2019;12:709\u201320.","journal-title":"OncoTargets therapy"},{"key":"2270_CR52","first-page":"101015","volume":"26","author":"DR Turkewitz","year":"2021","unstructured":"Turkewitz DR, Moghaddasi S, Alghalayini A, D\u2019Amario C, Ali HM, Wallach M, Valenzuela SM. Comparative study of His- and Non-His-tagged CLIC proteins, reveals changes in their enzymatic activity. Biochem Biophys Rep. 2021;26:101015.","journal-title":"Biochem Biophys Rep"},{"key":"2270_CR53","doi-asserted-by":"publisher","first-page":"14206","DOI":"10.1038\/ncomms14206","volume":"8","author":"JR Hernandez-Fernaud","year":"2017","unstructured":"Hernandez-Fernaud JR, Ruengeler E, Casazza A, Neilson LJ, Pulleine E, Santi A, Ismail S, Lilla S, Dhayade S, MacPherson IR, et al. Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity. Nat Commun. 2017;8:14206.","journal-title":"Nat Commun"},{"issue":"9","key":"2270_CR54","doi-asserted-by":"publisher","first-page":"102275","DOI":"10.1016\/j.jbc.2022.102275","volume":"298","author":"H Al Khamici","year":"2022","unstructured":"Al Khamici H, Sanchez VC, Yan H, Cataisson C, Michalowski AM, Yang HH, Li L, Lee MP, Huang J, Yuspa SH. The oxidoreductase CLIC4 is required to maintain mitochondrial function and resistance to exogenous oxidants in breast cancer cells. J Biol Chem. 2022;298(9):102275.","journal-title":"J Biol Chem"},{"issue":"21","key":"2270_CR55","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1080\/15384101.2017.1377031","volume":"16","author":"J Norman","year":"2017","unstructured":"Norman J, Zanivan S. Chloride intracellular channel 3: A secreted pro-invasive oxidoreductase. Cell Cycle. 2017;16(21):1993\u20134.","journal-title":"Cell Cycle"},{"issue":"1","key":"2270_CR56","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1186\/s12885-025-15205-6","volume":"25","author":"S Yuan","year":"2025","unstructured":"Yuan S, Li J, Liu W, Ren M, Lin L, Hao S, Yang L. CLIC3 emerges as a novel prognostic biomarker and therapeutic target in triple-negative breast cancer through integrated multi-omics analysis. BMC Cancer. 2025;25(1):1828.","journal-title":"BMC Cancer"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02270-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02270-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02270-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T04:48:21Z","timestamp":1778734101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02270-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2270"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02270-3","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed in accordance with institutional regulations after protocol review and approval by the University of Saskatchewan\u2019s Institutional Animal Care and Use Committee. The authors complied with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}